Evidence map›Paper›PMID 26029724›Full record

ArticleMolecular therapy. Methods & clinical development2015

Silencing p75(NTR) prevents proNGF-induced endothelial cell death and development of acellular capillaries in rat retina.

Ahmed Y Shanab, Barbara A Mysona, Suraporn Matragoon, Azza B El-Remessy

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Sortilin Inhibition Protects Neurons From Degeneration in the Diabetic Retina.Investigative ophthalmology & visual science · 2023
    Article
  4. Article
  5. In vivo functions of p75Trends in pharmacological sciences · 2021
    Review
  6. Article
  7. Modulation of p75International journal of molecular sciences · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Deletion of p75Scientific reports · 2018
    Article
  17. Article
  18. Article
  19. [Research progress of P75 neurotrophin receptor and new idea of nonunion treatment].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2017
    Review
  20. Implication of the neurotrophin receptor p75Expert review of ophthalmology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ahmed Y ShanabProgram in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia , Georgia, USA ; Culver Vision Discovery Institute, Georgia Regents University , Georgia, USA ; Charlie Norwood Veterans Affairs Medical Center , Augusta, Georgia, USA.
Barbara A MysonaProgram in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia , Georgia, USA ; Culver Vision Discovery Institute, Georgia Regents University , Georgia, USA ; Charlie Norwood Veterans Affairs Medical Center , Augusta, Georgia, USA.
Suraporn MatragoonProgram in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia , Georgia, USA ; Culver Vision Discovery Institute, Georgia Regents University , Georgia, USA ; Charlie Norwood Veterans Affairs Medical Center , Augusta, Georgia, USA.
Azza B El-RemessyProgram in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia , Georgia, USA ; Culver Vision Discovery Institute, Georgia Regents University , Georgia, USA ; Charlie Norwood Veterans Affairs Medical Center , Augusta, Georgia, USA.
University of Georgia · USDiscovery Institute · US

Funding

Molecular Mechanisms of diabetic retinopathyR01EY022408 · NEI · UNIVERSITY OF GEORGIA · PI EL-REMESSY, AZZA B · 2012 to 2016
$1.5M
NEI NIH HHS R01 EY022408
6 · The paper itself

Abstract

Accumulation of the nerve growth factor precursor (proNGF) and its receptor p75(NTR) have been associated with several neurodegenerative diseases in both brain and retina. However, whether proNGF contributes to microvascular degeneration remain unexplored. This study seeks to investigate the mechanism by which proNGF/p75(NTR) induce endothelial cell (EC) death and development of acellular capillaries, a surrogate marker of retinal ischemia. Stable overexpression of the cleavage-resistant proNGF and molecular silencing of p75(NTR) were utilized in human retinal EC and rat retinas in vivo. Stable overexpression of proNGF decreased NGF levels and induced retinal vascular cell death evident by 1.9-fold increase in acellular capillaries and activation of JNK and cleaved-PARP that were mitigated by p75(NTR)shRNA. In vitro, overexpression of proNGF did not alter TNF-α level, reduced NGF, however induced EC apoptosis evident by activation of JNK and p38 MAPK, cleaved-PARP. Silencing p75(NTR) using siRNA restored expression of NGF and TrkA activation and prevented EC apoptosis. Treatment of EC with human-mutant proNGF induced apoptosis that coincided with marked protein interaction and nuclear translocation of p75(NTR) and the neurotrophin receptor interacting factor. These effects were abolished by a selective p75(NTR) antagonist. Therefore, targeting p75(NTR) represents a potential therapeutic strategy for diseases associated with aberrant expression of proNGF.

Identifiers

PMID26029724
PMCPMC4445004
OpenAlexW650997508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.